Feedback (LON:FDBK) Trading Up 14.5% After Insider Buying Activity

Feedback plc (LON:FDBK)’s stock price shot up 14.5% during mid-day trading on Wednesday after an insider bought additional shares in the company. The company traded as high as GBX 9.45 and last traded at GBX 9.45. 232,118 shares traded hands during trading, an increase of 144% from the average session volume of 95,272 shares. The stock had previously closed at GBX 8.25.

Specifically, insider Emma Oswick (Stuart) purchased 60,459 shares of the company’s stock in a transaction that occurred on Tuesday, December 23rd. The stock was purchased at an average cost of GBX 8 per share, with a total value of £4,836.72. Also, insider Tom Oakley bought 60,904 shares of the firm’s stock in a transaction dated Tuesday, December 23rd. The shares were acquired at an average price of GBX 8 per share, for a total transaction of £4,872.32.

Feedback Stock Performance

The company’s 50-day moving average is GBX 8.47 and its 200-day moving average is GBX 11.50. The firm has a market cap of £4.14 million, a price-to-earnings ratio of -0.37 and a beta of 0.77.

About Feedback

Feedback plc (AIM: FDBK) provides innovative software and systems through its trading subsidiary, Feedback Medical.

Feedback liberates data and knowledge from multiple healthcare IT systems and delivers better workflows to enable clinicians to communicate, collaborate and provide the best healthcare for their patients. It connects care settings with diagnostic and other relevant data to drive better, faster, safer decision that improve outcomes for patients.

By linking different clinical systems together into a seamless view of the patient, Feedback can streamline patient pathways and deliver a digital health and diagnostics record across multiple care providers.

Bleepa® is a communication and collaboration platform that displays clinical results at a certified and regulated quality, which enables multi-disciplinary team working and diagnostic-enhanced advice and guidance.